img

Global COVID-19 In-Vitro Diagnostics Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global COVID-19 In-Vitro Diagnostics Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Due to the COVID-19 pandemic, the global COVID-19 In-Vitro Diagnostics market size was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the forecast period 2023-2033. Fully considering the economic change by this health crisis, Rapid Diagnostic Test (RDT) accounting for % of the COVID-19 In-Vitro Diagnostics global market in 2023, is projected to value US$ million by 2033, growing at a revised % CAGR from 2023 to 2033. While Home segment is altered to an % CAGR throughout this forecast period.
The global key companies of COVID-19 In-Vitro Diagnostics include Cellex, Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Bio-Tech, Mayo Clinic Laboratories and Chembio Diagnostics, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
The United States COVID-19 In-Vitro Diagnostics market size was US$ million in 2023, while China size was US$ million. The proportion of the United States was % in 2023, while China percentage was %, and it is predicted that China share will reach % in 2033, trailing a CAGR of % through the analysis period. As for the Europe COVID-19 In-Vitro Diagnostics landscape, Germany is projected to reach US$ million by 2033. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global COVID-19 In-Vitro Diagnostics market. The analysts authoring the report have closely studied key strategies adopted by top players of the global COVID-19 In-Vitro Diagnostics market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global COVID-19 In-Vitro Diagnostics market. Readers of the report can become informed about current and future trends of the global COVID-19 In-Vitro Diagnostics market and how they will impact market growth during the forecast period.



By Company


Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE
Segment by Type
Rapid Diagnostic Test (RDT)
Enzyme Linked Immunosorbent Assay (ELISA)
Neutralization Assay

Segment by Application


Home
Hospital
Clinical
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of COVID-19 In-Vitro Diagnostics in global and regional level.
Chapter 3Detailed analysis of COVID-19 In-Vitro Diagnostics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, COVID-19 In-Vitro Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 In-Vitro Diagnostics Market Size Growth Rate by Type: 2018 VS 2023 VS 2033
1.2.2 Rapid Diagnostic Test (RDT)
1.2.3 Enzyme Linked Immunosorbent Assay (ELISA)
1.2.4 Neutralization Assay
1.3 Market by Application
1.3.1 Global COVID-19 In-Vitro Diagnostics Market Growth Rate by Application: 2018 VS 2023 VS 2033
1.3.2 Home
1.3.3 Hospital
1.3.4 Clinical
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global COVID-19 In-Vitro Diagnostics Market Size (2018-2033)
2.2 COVID-19 In-Vitro Diagnostics Market Size across Key Geographies Worldwide: 2018 VS 2023 VS 2033
2.3 Global COVID-19 In-Vitro Diagnostics Market Size by Region (2018-2023)
2.4 Global COVID-19 In-Vitro Diagnostics Market Size Forecast by Region (2024-2033)
2.5 Global Top 10 COVID-19 In-Vitro Diagnostics Countries Ranking by Market Size
3 COVID-19 In-Vitro Diagnostics Competitive by Company
3.1 Global COVID-19 In-Vitro Diagnostics Revenue by Players
3.1.1 Global COVID-19 In-Vitro Diagnostics Revenue by Players (2018-2023)
3.1.2 Global COVID-19 In-Vitro Diagnostics Market Share by Players (2018-2023)
3.2 Global COVID-19 In-Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by COVID-19 In-Vitro Diagnostics Revenue
3.4 Global COVID-19 In-Vitro Diagnostics Market Concentration Ratio
3.4.1 Global COVID-19 In-Vitro Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COVID-19 In-Vitro Diagnostics Revenue in 2023
3.5 Global Key Players of COVID-19 In-Vitro Diagnostics Head office and Area Served
3.6 Global Key Players of COVID-19 In-Vitro Diagnostics, Product and Application
3.7 Global Key Players of COVID-19 In-Vitro Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global COVID-19 In-Vitro Diagnostics Breakdown Data by Type
4.1 Global COVID-19 In-Vitro Diagnostics Historic Revenue by Type (2018-2023)
4.2 Global COVID-19 In-Vitro Diagnostics Forecasted Revenue by Type (2024-2033)
5 Global COVID-19 In-Vitro Diagnostics Breakdown Data by Application
5.1 Global COVID-19 In-Vitro Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global COVID-19 In-Vitro Diagnostics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America COVID-19 In-Vitro Diagnostics Revenue by Company (2021-2023)
6.2 North America COVID-19 In-Vitro Diagnostics Revenue by Type (2018-2033)
6.3 North America COVID-19 In-Vitro Diagnostics Revenue by Application (2018-2033)
6.4 North America COVID-19 In-Vitro Diagnostics Revenue by Country (2018-2033)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe COVID-19 In-Vitro Diagnostics Revenue by Company (2021-2023)
7.2 Europe COVID-19 In-Vitro Diagnostics Revenue by Type (2018-2033)
7.3 Europe COVID-19 In-Vitro Diagnostics Revenue by Application (2018-2033)
7.4 Europe COVID-19 In-Vitro Diagnostics Revenue by Country (2018-2033)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific COVID-19 In-Vitro Diagnostics Revenue by Company (2021-2023)
8.2 Asia Pacific COVID-19 In-Vitro Diagnostics Revenue by Type (2018-2033)
8.3 Asia Pacific COVID-19 In-Vitro Diagnostics Revenue by Application (2018-2033)
8.4 Asia Pacific COVID-19 In-Vitro Diagnostics Revenue by Region (2018-2033)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America COVID-19 In-Vitro Diagnostics Revenue by Company (2021-2023)
9.2 Latin America COVID-19 In-Vitro Diagnostics Revenue by Type (2018-2033)
9.3 Latin America COVID-19 In-Vitro Diagnostics Revenue by Application (2018-2033)
9.4 Latin America COVID-19 In-Vitro Diagnostics Revenue by Country (2018-2033)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa COVID-19 In-Vitro Diagnostics Revenue by Company (2021-2023)
10.2 Middle East and Africa COVID-19 In-Vitro Diagnostics Revenue by Type (2018-2033)
10.3 Middle East and Africa COVID-19 In-Vitro Diagnostics Revenue by Application (2018-2033)
10.4 Middle East and Africa COVID-19 In-Vitro Diagnostics Revenue by Country (2018-2033)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Cellex
11.1.1 Cellex Company Details
11.1.2 Cellex Business Overview
11.1.3 Cellex COVID-19 In-Vitro Diagnostics Products and Services
11.1.4 Cellex COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.1.5 Cellex COVID-19 In-Vitro Diagnostics SWOT Analysis
11.1.6 Cellex Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott COVID-19 In-Vitro Diagnostics Products and Services
11.2.4 Abbott COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.2.5 Abbott COVID-19 In-Vitro Diagnostics SWOT Analysis
11.2.6 Abbott Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche COVID-19 In-Vitro Diagnostics Products and Services
11.3.4 Roche COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.3.5 Roche COVID-19 In-Vitro Diagnostics SWOT Analysis
11.3.6 Roche Recent Development
11.4 BioMedomics
11.4.1 BioMedomics Company Details
11.4.2 BioMedomics Business Overview
11.4.3 BioMedomics COVID-19 In-Vitro Diagnostics Products and Services
11.4.4 BioMedomics COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.4.5 BioMedomics COVID-19 In-Vitro Diagnostics SWOT Analysis
11.4.6 BioMedomics Recent Development
11.5 BD
11.5.1 BD Company Details
11.5.2 BD Business Overview
11.5.3 BD COVID-19 In-Vitro Diagnostics Products and Services
11.5.4 BD COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.5.5 BD COVID-19 In-Vitro Diagnostics SWOT Analysis
11.5.6 BD Recent Development
11.6 Henry Schein
11.6.1 Henry Schein Company Details
11.6.2 Henry Schein Business Overview
11.6.3 Henry Schein COVID-19 In-Vitro Diagnostics Products and Services
11.6.4 Henry Schein COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.6.5 Henry Schein COVID-19 In-Vitro Diagnostics SWOT Analysis
11.6.6 Henry Schein Recent Development
11.7 Safecare Bio-Tech
11.7.1 Safecare Bio-Tech Company Details
11.7.2 Safecare Bio-Tech Business Overview
11.7.3 Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Products and Services
11.7.4 Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.7.5 Safecare Bio-Tech COVID-19 In-Vitro Diagnostics SWOT Analysis
11.7.6 Safecare Bio-Tech Recent Development
11.8 Mayo Clinic Laboratories
11.8.1 Mayo Clinic Laboratories Company Details
11.8.2 Mayo Clinic Laboratories Business Overview
11.8.3 Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Products and Services
11.8.4 Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.8.5 Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics SWOT Analysis
11.8.6 Mayo Clinic Laboratories Recent Development
11.9 Chembio Diagnostics
11.9.1 Chembio Diagnostics Company Details
11.9.2 Chembio Diagnostics Business Overview
11.9.3 Chembio Diagnostics COVID-19 In-Vitro Diagnostics Products and Services
11.9.4 Chembio Diagnostics COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.9.5 Chembio Diagnostics COVID-19 In-Vitro Diagnostics SWOT Analysis
11.9.6 Chembio Diagnostics Recent Development
11.10 Mount Sinai Laboratory
11.10.1 Mount Sinai Laboratory Company Details
11.10.2 Mount Sinai Laboratory Business Overview
11.10.3 Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Products and Services
11.10.4 Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.10.5 Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics SWOT Analysis
11.10.6 Mount Sinai Laboratory Recent Development
11.11 Ortho Clinical Diagnostics
11.11.1 Ortho Clinical Diagnostics Company Details
11.11.2 Ortho Clinical Diagnostics Business Overview
11.11.3 Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Products and Services
11.11.4 Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.11.5 Ortho Clinical Diagnostics Recent Development
11.12 Zhejiang Orient Gene Biotech
11.12.1 Zhejiang Orient Gene Biotech Company Details
11.12.2 Zhejiang Orient Gene Biotech Business Overview
11.12.3 Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Products and Services
11.12.4 Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.12.5 Zhejiang Orient Gene Biotech Recent Development
11.13 Innovita Biological Technology
11.13.1 Innovita Biological Technology Company Details
11.13.2 Innovita Biological Technology Business Overview
11.13.3 Innovita Biological Technology COVID-19 In-Vitro Diagnostics Products and Services
11.13.4 Innovita Biological Technology COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.13.5 Innovita Biological Technology Recent Development
11.14 Guangzhou Wondfo Biotech
11.14.1 Guangzhou Wondfo Biotech Company Details
11.14.2 Guangzhou Wondfo Biotech Business Overview
11.14.3 Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Products and Services
11.14.4 Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.14.5 Guangzhou Wondfo Biotech Recent Development
11.15 Guangdong Hecin-Scientific
11.15.1 Guangdong Hecin-Scientific Company Details
11.15.2 Guangdong Hecin-Scientific Business Overview
11.15.3 Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Products and Services
11.15.4 Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.15.5 Guangdong Hecin-Scientific Recent Development
11.16 Dynamiker Biotechnology (Tianjin)
11.16.1 Dynamiker Biotechnology (Tianjin) Company Details
11.16.2 Dynamiker Biotechnology (Tianjin) Business Overview
11.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Products and Services
11.16.4 Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.16.5 Dynamiker Biotechnology (Tianjin) Recent Development
11.17 ADVAITE
11.17.1 ADVAITE Company Details
11.17.2 ADVAITE Business Overview
11.17.3 ADVAITE COVID-19 In-Vitro Diagnostics Products and Services
11.17.4 ADVAITE COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.17.5 ADVAITE Recent Development
12 COVID-19 In-Vitro Diagnostics Market Dynamics
12.1 COVID-19 In-Vitro Diagnostics Industry Trends
12.2 COVID-19 In-Vitro Diagnostics Market Drivers
12.3 COVID-19 In-Vitro Diagnostics Market Challenges
12.4 COVID-19 In-Vitro Diagnostics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global COVID-19 In-Vitro Diagnostics Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2023 VS 2033
Table 2. Key Players of Rapid Diagnostic Test (RDT)
Table 3. Key Players of Enzyme Linked Immunosorbent Assay (ELISA)
Table 4. Key Players of Neutralization Assay
Table 5. Global COVID-19 In-Vitro Diagnostics Market Size Growth Rate by Application (US$ Million), 2018 VS 2023 VS 2033
Table 6. Global COVID-19 In-Vitro Diagnostics Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2023 VS 2033
Table 7. Global COVID-19 In-Vitro Diagnostics Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global COVID-19 In-Vitro Diagnostics Revenue Forecast by Region (2024-2033) & (US$ Million)
Table 9. Global COVID-19 In-Vitro Diagnostics Market Size of Top 10 Countries, 2018 VS 2023 VS 2033, (US$ Million)
Table 10. Global COVID-19 In-Vitro Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 11. Global COVID-19 In-Vitro Diagnostics Market Share by Players (2018-2023)
Table 12. Global Top COVID-19 In-Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 In-Vitro Diagnostics as of 2023)
Table 13. Ranking of Global Top COVID-19 In-Vitro Diagnostics Companies by Revenue (US$ Million) in 2023
Table 14. Global 5 Largest Players Market Share by COVID-19 In-Vitro Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 15. Global Key Players of COVID-19 In-Vitro Diagnostics, Headquarters and Area Served
Table 16. Global Key Players of COVID-19 In-Vitro Diagnostics, Product and Application
Table 17. Global Key Players of COVID-19 In-Vitro Diagnostics, Date of Enter into This Industry
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global COVID-19 In-Vitro Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 20. Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Type (2018-2023)
Table 21. Global COVID-19 In-Vitro Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 22. Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Type (2024-2033)
Table 23. Global COVID-19 In-Vitro Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 24. Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Application (2018-2023)
Table 25. Global COVID-19 In-Vitro Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 26. Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Application (2024-2033)
Table 27. North America COVID-19 In-Vitro Diagnostics Revenue by Company (2021-2023) & (US$ Million)
Table 28. North America COVID-19 In-Vitro Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 29. North America COVID-19 In-Vitro Diagnostics Revenue by Type (2024-2033) & (US$ Million)
Table 30. North America COVID-19 In-Vitro Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 31. North America COVID-19 In-Vitro Diagnostics Revenue by Application (2024-2033) & (US$ Million)
Table 32. North America COVID-19 In-Vitro Diagnostics Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 33. North America COVID-19 In-Vitro Diagnostics Revenue by Country (2018-2023) & (US$ Million)
Table 34. North America COVID-19 In-Vitro Diagnostics Revenue by Country (2024-2033) & (US$ Million)
Table 35. Europe COVID-19 In-Vitro Diagnostics Revenue by Company (2021-2023) & (US$ Million)
Table 36. Europe COVID-19 In-Vitro Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 37. Europe COVID-19 In-Vitro Diagnostics Revenue by Type (2024-2033) & (US$ Million)
Table 38. Europe COVID-19 In-Vitro Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 39. Europe COVID-19 In-Vitro Diagnostics Revenue by Application (2024-2033) & (US$ Million)
Table 40. Europe COVID-19 In-Vitro Diagnostics Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 41. Europe COVID-19 In-Vitro Diagnostics Revenue by Country (2018-2023) & (US$ Million)
Table 42. Europe COVID-19 In-Vitro Diagnostics Revenue by Country (2024-2033) & (US$ Million)
Table 43. Asia Pacific COVID-19 In-Vitro Diagnostics Revenue by Company (2021-2023) & (US$ Million)
Table 44. Asia Pacific COVID-19 In-Vitro Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 45. Asia Pacific COVID-19 In-Vitro Diagnostics Revenue by Type (2024-2033) & (US$ Million)
Table 46. Asia Pacific COVID-19 In-Vitro Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 47. Asia Pacific COVID-19 In-Vitro Diagnostics Revenue by Application (2024-2033) & (US$ Million)
Table 48. Asia-Pacific COVID-19 In-Vitro Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 49. Asia Pacific COVID-19 In-Vitro Diagnostics Revenue by Region (2018-2023) & (US$ Million)
Table 50. Asia Pacific COVID-19 In-Vitro Diagnostics Revenue by Region (2024-2033) & (US$ Million)
Table 51. Latin America COVID-19 In-Vitro Diagnostics Revenue by Company (2021-2023) & (US$ Million)
Table 52. Latin America COVID-19 In-Vitro Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 53. Latin America COVID-19 In-Vitro Diagnostics Revenue by Type (2024-2033) & (US$ Million)
Table 54. Latin America COVID-19 In-Vitro Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 55. Latin America COVID-19 In-Vitro Diagnostics Revenue by Application (2024-2033) & (US$ Million)
Table 56. Latin America COVID-19 In-Vitro Diagnostics Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 57. Latin America COVID-19 In-Vitro Diagnostics Revenue by Country (2018-2023) & (US$ Million)
Table 58. Latin America COVID-19 In-Vitro Diagnostics Revenue by Country (2024-2033) & (US$ Million)
Table 59. Middle East and Africa COVID-19 In-Vitro Diagnostics Revenue by Company (2021-2023) & (US$ Million)
Table 60. Middle East and Africa COVID-19 In-Vitro Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 61. Middle East and Africa COVID-19 In-Vitro Diagnostics Revenue by Type (2024-2033) & (US$ Million)
Table 62. Middle East and Africa COVID-19 In-Vitro Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 63. Middle East and Africa COVID-19 In-Vitro Diagnostics Revenue by Application (2024-2033) & (US$ Million)
Table 64. Middle East and Africa COVID-19 In-Vitro Diagnostics Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 65. Middle East and Africa COVID-19 In-Vitro Diagnostics Revenue by Country (2018-2023) & (US$ Million)
Table 66. Middle East and Africa COVID-19 In-Vitro Diagnostics Revenue by Country (2024-2033) & (US$ Million)
Table 67. Cellex Company Details
Table 68. Cellex Business Overview
Table 69. Cellex COVID-19 In-Vitro Diagnostics Product and Services
Table 70. Cellex COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 71. Cellex COVID-19 In-Vitro Diagnostics SWOT Analysis
Table 72. Cellex Recent Development
Table 73. Abbott Company Details
Table 74. Abbott Business Overview
Table 75. Abbott COVID-19 In-Vitro Diagnostics Product and Services
Table 76. Abbott COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 77. Abbott COVID-19 In-Vitro Diagnostics SWOT Analysis
Table 78. Abbott Recent Development
Table 79. Roche Company Details
Table 80. Roche Business Overview
Table 81. Roche COVID-19 In-Vitro Diagnostics Product and Services
Table 82. Roche COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 83. Roche COVID-19 In-Vitro Diagnostics SWOT Analysis
Table 84. Roche Recent Development
Table 85. BioMedomics Company Details
Table 86. BioMedomics Business Overview
Table 87. BioMedomics COVID-19 In-Vitro Diagnostics Product and Services
Table 88. BioMedomics COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 89. BioMedomics COVID-19 In-Vitro Diagnostics SWOT Analysis
Table 90. BioMedomics Recent Development
Table 91. BD Company Details
Table 92. BD Business Overview
Table 93. BD COVID-19 In-Vitro Diagnostics Product and Services
Table 94. BD COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 95. BD COVID-19 In-Vitro Diagnostics SWOT Analysis
Table 96. BD Recent Development
Table 97. Henry Schein Company Details
Table 98. Henry Schein Business Overview
Table 99. Henry Schein COVID-19 In-Vitro Diagnostics Product and Services
Table 100. Henry Schein COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 101. Henry Schein COVID-19 In-Vitro Diagnostics SWOT Analysis
Table 102. Henry Schein Recent Development
Table 103. Safecare Bio-Tech Company Details
Table 104. Safecare Bio-Tech Business Overview
Table 105. Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Product and Services
Table 106. Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 107. Safecare Bio-Tech COVID-19 In-Vitro Diagnostics SWOT Analysis
Table 108. Safecare Bio-Tech Recent Development
Table 109. Mayo Clinic Laboratories Company Details
Table 110. Mayo Clinic Laboratories Business Overview
Table 111. Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Product and Services
Table 112. Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 113. Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics SWOT Analysis
Table 114. Mayo Clinic Laboratories Recent Development
Table 115. Chembio Diagnostics Company Details
Table 116. Chembio Diagnostics Business Overview
Table 117. Chembio Diagnostics COVID-19 In-Vitro Diagnostics Product and Services
Table 118. Chembio Diagnostics COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 119. Chembio Diagnostics COVID-19 In-Vitro Diagnostics SWOT Analysis
Table 120. Chembio Diagnostics Recent Development
Table 121. Mount Sinai Laboratory Company Details
Table 122. Mount Sinai Laboratory Business Overview
Table 123. Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Product and Services
Table 124. Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 125. Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics SWOT Analysis
Table 126. Mount Sinai Laboratory Recent Development
Table 127. Ortho Clinical Diagnostics Company Details
Table 128. Ortho Clinical Diagnostics Business Overview
Table 129. Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Product and Services
Table 130. Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 131. Ortho Clinical Diagnostics Recent Development
Table 132. Zhejiang Orient Gene Biotech Company Details
Table 133. Zhejiang Orient Gene Biotech Business Overview
Table 134. Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Product and Services
Table 135. Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 136. Zhejiang Orient Gene Biotech Recent Development
Table 137. Innovita Biological Technology Company Details
Table 138. Innovita Biological Technology Business Overview
Table 139. Innovita Biological Technology COVID-19 In-Vitro Diagnostics Product and Services
Table 140. Innovita Biological Technology COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 141. Innovita Biological Technology Recent Development
Table 142. Guangzhou Wondfo Biotech Company Details
Table 143. Guangzhou Wondfo Biotech Business Overview
Table 144. Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Product and Services
Table 145. Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 146. Guangzhou Wondfo Biotech Recent Development
Table 147. Guangdong Hecin-Scientific Company Details
Table 148. Guangdong Hecin-Scientific Business Overview
Table 149. Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Product and Services
Table 150. Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 151. Guangdong Hecin-Scientific Recent Development
Table 152. Dynamiker Biotechnology (Tianjin) Company Details
Table 153. Dynamiker Biotechnology (Tianjin) Business Overview
Table 154. Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Product and Services
Table 155. Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 156. Dynamiker Biotechnology (Tianjin) Recent Development
Table 157. ADVAITE Company Details
Table 158. ADVAITE Business Overview
Table 159. ADVAITE COVID-19 In-Vitro Diagnostics Product and Services
Table 160. ADVAITE COVID-19 In-Vitro Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 161. ADVAITE Recent Development
Table 162. COVID-19 In-Vitro Diagnostics Market Trends
Table 163. COVID-19 In-Vitro Diagnostics Market Drivers
Table 164. COVID-19 In-Vitro Diagnostics Market Challenges
Table 165. COVID-19 In-Vitro Diagnostics Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. COVID-19 In-Vitro Diagnostics Product Picture
Figure 2. Global COVID-19 In-Vitro Diagnostics Market Size by Type (US$ Million): 2018 VS 2023 VS 2033
Figure 3. Global COVID-19 In-Vitro Diagnostics Market Share by Type: 2023 VS 2033
Figure 4. Rapid Diagnostic Test (RDT) Features
Figure 5. Enzyme Linked Immunosorbent Assay (ELISA) Features
Figure 6. Neutralization Assay Features
Figure 7. Global COVID-19 In-Vitro Diagnostics Market Size by Application (US$ Million): 2018 VS 2023 VS 2033
Figure 8. Global COVID-19 In-Vitro Diagnostics Market Share by Application: 2023 VS 2033
Figure 9. Home
Figure 10. Hospital
Figure 11. Clinical
Figure 12. COVID-19 In-Vitro Diagnostics Report Years Considered
Figure 13. Global COVID-19 In-Vitro Diagnostics Revenue, (US$ Million), 2018 VS 2023 VS 2033
Figure 14. Global COVID-19 In-Vitro Diagnostics Market Size 2018-2033 (US$ Million)
Figure 15. Global COVID-19 In-Vitro Diagnostics Market Size Market Share by Region: 2023 VS 2033
Figure 16. Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Region in 2018 VS 2023
Figure 17. Global COVID-19 In-Vitro Diagnostics Revenue Market Share Forecast by Region (2024-2033)
Figure 18. Global Top 10 COVID-19 In-Vitro Diagnostics Countries Ranking by Market Size (US$ Million) in 2023
Figure 19. Global COVID-19 In-Vitro Diagnostics Market Size of Top 10 Countries, 2018 VS 2023 VS 2033, (US$ Million)
Figure 20. Global COVID-19 In-Vitro Diagnostics Market Share by Players in 2023
Figure 21. Global Top COVID-19 In-Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 In-Vitro Diagnostics as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by COVID-19 In-Vitro Diagnostics Revenue in 2023
Figure 23. North America COVID-19 In-Vitro Diagnostics Revenue Market Share by Company in 2023
Figure 24. North America COVID-19 In-Vitro Diagnostics Revenue Market Share by Type (2018-2033)
Figure 25. North America COVID-19 In-Vitro Diagnostics Revenue Market Share by Application (2018-2033)
Figure 26. North America COVID-19 In-Vitro Diagnostics Revenue Share by Country (2018-2033)
Figure 27. U.S. COVID-19 In-Vitro Diagnostics Revenue (2018-2033) & (US$ Million)
Figure 28. Canada COVID-19 In-Vitro Diagnostics Revenue (2018-2033) & (US$ Million)
Figure 29. Europe COVID-19 In-Vitro Diagnostics Revenue Market Share by Company in 2023
Figure 30. Europe COVID-19 In-Vitro Diagnostics Revenue Market Share by Type (2018-2033)
Figure 31. Europe COVID-19 In-Vitro Diagnostics Revenue Market Share by Application (2018-2033)
Figure 32. Europe COVID-19 In-Vitro Diagnostics Revenue Share by Country (2018-2033)
Figure 33. Germany COVID-19 In-Vitro Diagnostics Revenue (2018-2033) & (US$ Million)
Figure 34. France COVID-19 In-Vitro Diagnostics Revenue (2018-2033) & (US$ Million)
Figure 35. U.K. COVID-19 In-Vitro Diagnostics Revenue (2018-2033) & (US$ Million)
Figure 36. Italy COVID-19 In-Vitro Diagnostics Revenue (2018-2033) & (US$ Million)
Figure 37. Russia COVID-19 In-Vitro Diagnostics Revenue (2018-2033) & (US$ Million)
Figure 38. Asia Pacific COVID-19 In-Vitro Diagnostics Revenue Market Share by Company in 2023
Figure 39. Asia Pacific COVID-19 In-Vitro Diagnostics Revenue Market Share by Type (2018-2033)
Figure 40. Asia Pacific COVID-19 In-Vitro Diagnostics Revenue Market Share by Application (2018-2033)
Figure 41. Asia Pacific COVID-19 In-Vitro Diagnostics Revenue Share by Region (2018-2033)
Figure 42. China COVID-19 In-Vitro Diagnostics Revenue (2018-2033) & (US$ Million)
Figure 43. Japan COVID-19 In-Vitro Diagnostics Revenue (2018-2033) & (US$ Million)
Figure 44. South Korea COVID-19 In-Vitro Diagnostics Revenue (2018-2033) & (US$ Million)
Figure 45. India COVID-19 In-Vitro Diagnostics Revenue (2018-2033) & (US$ Million)
Figure 46. Australia COVID-19 In-Vitro Diagnostics Revenue (2018-2033) & (US$ Million)
Figure 47. Taiwan COVID-19 In-Vitro Diagnostics Revenue (2018-2033) & (US$ Million)
Figure 48. Indonesia COVID-19 In-Vitro Diagnostics Revenue (2018-2033) & (US$ Million)
Figure 49. Thailand COVID-19 In-Vitro Diagnostics Revenue (2018-2033) & (US$ Million)
Figure 50. Malaysia COVID-19 In-Vitro Diagnostics Revenue (2018-2033) & (US$ Million)
Figure 51. Philippines COVID-19 In-Vitro Diagnostics Revenue (2018-2033) & (US$ Million)
Figure 52. Vietnam COVID-19 In-Vitro Diagnostics Revenue (2018-2033) & (US$ Million)
Figure 53. Latin America COVID-19 In-Vitro Diagnostics Revenue Market Share by Company in 2023
Figure 54. Latin America COVID-19 In-Vitro Diagnostics Revenue Market Share by Type (2018-2033)
Figure 55. Latin America COVID-19 In-Vitro Diagnostics Revenue Market Share by Application (2018-2033)
Figure 56. Latin America COVID-19 In-Vitro Diagnostics Revenue Share by Country (2018-2033)
Figure 57. Mexico COVID-19 In-Vitro Diagnostics Revenue (2018-2033) & (US$ Million)
Figure 58. Brazil COVID-19 In-Vitro Diagnostics Revenue (2018-2033) & (US$ Million)
Figure 59. Argentina COVID-19 In-Vitro Diagnostics Revenue (2018-2033) & (US$ Million)
Figure 60. Middle East and Africa COVID-19 In-Vitro Diagnostics Revenue Market Share by Company in 2023
Figure 61. Middle East and Africa COVID-19 In-Vitro Diagnostics Revenue Market Share by Type (2018-2033)
Figure 62. Middle East and Africa COVID-19 In-Vitro Diagnostics Revenue Market Share by Application (2018-2033)
Figure 63. Middle East and Africa COVID-19 In-Vitro Diagnostics Revenue Share by Country (2018-2033)
Figure 64. Turkey COVID-19 In-Vitro Diagnostics Revenue (2018-2033) & (US$ Million)
Figure 65. Saudi Arabia COVID-19 In-Vitro Diagnostics Revenue (2018-2033) & (US$ Million)
Figure 66. UAE COVID-19 In-Vitro Diagnostics Revenue (2018-2033) & (US$ Million)
Figure 67. Cellex Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 68. Abbott Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 69. Roche Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 70. BioMedomics Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 71. BD Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 72. Henry Schein Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 73. Safecare Bio-Tech Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 74. Mayo Clinic Laboratories Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 75. Chembio Diagnostics Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 76. Mount Sinai Laboratory Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 77. Ortho Clinical Diagnostics Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 78. Zhejiang Orient Gene Biotech Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 79. Innovita Biological Technology Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 80. Guangzhou Wondfo Biotech Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 81. Guangdong Hecin-Scientific Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 82. Dynamiker Biotechnology (Tianjin) Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 83. ADVAITE Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries